Jefferies Financial Group Analysts Reduce Earnings Estimates for Ventas, Inc. (NYSE:VTR)

Ventas, Inc. (NYSE:VTR) – Jefferies Financial Group cut their Q2 2019 earnings per share (EPS) estimates for Ventas in a report issued on Monday, July 15th. Jefferies Financial Group analyst J. Petersen now expects that the real estate investment trust will post earnings of $0.95 per share for the quarter, down from their previous estimate of $0.96. Jefferies Financial Group also issued estimates for Ventas’ Q3 2019 earnings at $0.91 EPS, FY2019 earnings at $3.79 EPS, Q1 2020 earnings at $0.96 EPS, Q2 2020 earnings at $0.99 EPS, Q3 2020 earnings at $1.01 EPS, Q4 2020 earnings at $1.03 EPS, FY2020 earnings at $3.99 EPS, Q1 2021 earnings at $1.01 EPS, Q2 2021 earnings at $1.03 EPS and FY2021 earnings at $4.21 EPS.

Ventas (NYSE:VTR) last released its quarterly earnings results on Friday, April 26th. The real estate investment trust reported $0.99 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.96 by $0.03. Ventas had a return on equity of 4.04% and a net margin of 12.19%. The company had revenue of $942.80 million during the quarter, compared to analysts’ expectations of $908.61 million. During the same period in the previous year, the firm posted $0.22 earnings per share. The business’s revenue for the quarter was down .1% compared to the same quarter last year.

Several other equities analysts have also commented on VTR. Morgan Stanley set a $111.00 target price on Procter & Gamble and gave the company a “buy” rating in a research note on Thursday, March 28th. Deutsche Bank upped their target price on Welltower from $61.00 to $71.00 and gave the company a “hold” rating in a research note on Friday, March 29th. Citigroup set a $14.00 target price on General Electric and gave the company a “buy” rating in a research note on Wednesday, June 19th. BMO Capital Markets reiterated a “market perform” rating and issued a $73.00 target price on shares of Ventas in a research note on Wednesday, June 19th. Finally, Bank of America set a $300.00 target price on IDEXX Laboratories and gave the company a “buy” rating in a research note on Friday, June 21st. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company’s stock. Ventas has a consensus rating of “Hold” and a consensus target price of $64.82.

NYSE VTR opened at $68.60 on Tuesday. Ventas has a fifty-two week low of $51.80 and a fifty-two week high of $73.74. The firm has a market capitalization of $24.59 billion, a PE ratio of 16.86, a price-to-earnings-growth ratio of 4.48 and a beta of 0.28. The business has a fifty day moving average of $67.61. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.56 and a current ratio of 0.56.

A number of hedge funds have recently bought and sold shares of the business. Hoylecohen LLC boosted its position in shares of Ventas by 0.7% in the first quarter. Hoylecohen LLC now owns 80,145 shares of the real estate investment trust’s stock worth $5,114,000 after buying an additional 560 shares during the period. Proffitt & Goodson Inc. purchased a new stake in shares of Ventas in the first quarter worth about $88,000. Kaizen Advisory LLC boosted its position in shares of Ventas by 27.6% in the fourth quarter. Kaizen Advisory LLC now owns 1,007 shares of the real estate investment trust’s stock worth $59,000 after buying an additional 218 shares during the period. Intrust Bank NA purchased a new stake in shares of Ventas in the first quarter worth about $200,000. Finally, Aspire Private Capital LLC purchased a new stake in shares of Ventas in the fourth quarter worth about $401,000. 87.10% of the stock is owned by hedge funds and other institutional investors.

In other Ventas news, Chairman Debra A. Cafaro sold 68,080 shares of the business’s stock in a transaction dated Wednesday, June 19th. The stock was sold at an average price of $69.04, for a total transaction of $4,700,243.20. Following the completion of the sale, the chairman now owns 741,358 shares of the company’s stock, valued at $51,183,356.32. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP T Richard Riney sold 29,702 shares of the business’s stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $70.45, for a total value of $2,092,505.90. Following the sale, the executive vice president now directly owns 163,488 shares of the company’s stock, valued at approximately $11,517,729.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 165,866 shares of company stock valued at $11,323,058. 1.40% of the stock is owned by company insiders.

The company also recently declared a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Monday, July 1st were given a dividend of $0.7925 per share. This represents a $3.17 dividend on an annualized basis and a yield of 4.62%. The ex-dividend date of this dividend was Friday, June 28th. Ventas’s dividend payout ratio (DPR) is presently 77.89%.

About Ventas

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.

Featured Story: What are convertible shares? 

Earnings History and Estimates for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.